Pharsight

INTAS PHARMACEUTICALS LTD patents facing oppositions

Top patents of INTAS PHARMACEUTICALS LTD facing oppositions at the European Patent Office (EPO).

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3833335B1 31 Aug, 2022 Pharmaceutical composition comprising hmg-coa reductase inhibitors and fenofibrate Jul, 2040 1